menu search

Ad hoc announcement pursuant to art. 53 lr: genentech's anti-amyloid beta antibody gantenerumab granted fda breakthrough therapy designation in alzheimer's disease

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--genentech, a member of the Roche Group (SIX: RO, ROG; OTC...

October 8, 2021, 11:40 am

genentech to present new data on ocrevus (ocrelizumab) in multiple sclerosis and enspryng (satralizumab-mwge) in neuromyelitis optica spectrum disorder at ectrims 2021

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--genentech, a member of the Roche Group (SIX: RO, ROG; OTC...

October 5, 2021, 1:00 am

genentech to present new data on ocrevus (ocrelizumab) in multiple sclerosis and enspryng (satralizumab-mwge) in neuromyelitis optica spectrum disorder at ectrims 2021

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--genentech, a member of the Roche Group (SIX: RO, ROG; OTC...

October 5, 2021, 1:00 am

genentech to present new data on ocrevus (ocrelizumab) in multiple sclerosis and enspryng (satralizumab-mwge) in neuromyelitis optica spectrum disorder at ectrims 2021

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--genentech, a member of the Roche Group (SIX: RO, ROG; OTC...

October 5, 2021, 1:00 am

genentech to present new data on ocrevus (ocrelizumab) in multiple sclerosis and enspryng (satralizumab-mwge) in neuromyelitis optica spectrum disorder at ectrims 2021

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--genentech, a member of the Roche Group (SIX: RO, ROG; OTC...

October 5, 2021, 1:00 am

genentech to present new data on ocrevus (ocrelizumab) in multiple sclerosis and enspryng (satralizumab-mwge) in neuromyelitis optica spectrum disorder at ectrims 2021

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--genentech, a member of the Roche Group (SIX: RO, ROG; OTC...

October 5, 2021, 1:00 am

genentech to present new data on ocrevus (ocrelizumab) in multiple sclerosis and enspryng (satralizumab-mwge) in neuromyelitis optica spectrum disorder at ectrims 2021

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--genentech, a member of the Roche Group (SIX: RO, ROG; OTC...

October 5, 2021, 1:00 am

genentech to present new data on ocrevus (ocrelizumab) in multiple sclerosis and enspryng (satralizumab-mwge) in neuromyelitis optica spectrum disorder at ectrims 2021

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--genentech, a member of the Roche Group (SIX: RO, ROG; OTC...

October 5, 2021, 1:00 am


Search within

Pages Search Results: